MIYAKO CAPITAL
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services. 2) Agri-Food: Industrialization, agricultural and fishery products growth-promoting technology, specified health food, health food. 3) Environment, Energy: Alternative energy, and related techn... ologies. 4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot. 5) New services utilizing state-of-art technology. Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Similar Organizations
Maven 11 Capital
Venture Capital Fund in Blockchain & Distributed Ledger Technology (DLT)
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-03-02 | Social Good Foundation Inc. | Miyako Capital investment in Series A - Social Good Foundation Inc. | 14.2 M USD |
2021-12-27 | VLP Therapeutics | Miyako Capital investment in Series A - VLP Therapeutics | 21 M USD |
2021-07-01 | VividQ | Miyako Capital investment in Seed Round - VividQ | 11 M GBP |
2021-05-12 | Startbahn | Miyako Capital investment in Series B - Startbahn | 1.12 B JPY |
2021-03-15 | VLP Therapeutics | Miyako Capital investment in Series A - VLP Therapeutics | 16 M USD |
2020-11-16 | HACARUS | Miyako Capital investment in Series B - HACARUS | 1.3 B JPY |
2020-10-26 | Floadia Corporation | Miyako Capital investment in Series C - Floadia Corporation | 1.04 B JPY |
2020-09-25 | Varinos | Miyako Capital investment in Seed Round - Varinos | 300 M JPY |
2020-09-11 | CellAxia | Miyako Capital investment in Series B - CellAxia | 700 M JPY |
2020-04-30 | Liberaware | Miyako Capital investment in Venture Round - Liberaware | 260 M JPY |